Observing her husband, columnist Alliah Czarielle sees that getting older is a great equalizer, as more in their community have health woes.

Two hemophilia patients in the U.S. who struggled for years with bleeds have been given Hemgenix, the first gene therapy ...

Columnist Jennifer Lynne reflects on her most-read columns from last year and why those stories resonated with the hemophilia community.

Two new patients in the U.S. have received Hemgenix (etranacogene dezaparvovec), the first gene therapy to be approved for hemophilia B, per new reports. The therapy was first administered last year ...

Columnist Joe MacDonald's son struggled to balance school and hemophilia during his first semester of college. Now, he's better prepared.